MEREO BIOPHARMA GROUP PLC

Insiders Mereo BioPharma Group plc

Equities

MREO

US5894921072

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
3.03 ^USD	-7.34%		-7.06%	+31.17%

05-10	European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	MT
05-03	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mereo BioPharma Group plc Announces Board Changes	28/10/22	CI
Mereo BioPharma Group plc Announces Board Changes	17/05/22	CI
Mereo BioPharma Group plc Announces Appointment of Anne Hyland to Board of Directors	01/03/22	CI
Mereo Biopharma Announces Board Changes	20/09/21	CI
Mereo Biopharma Group plc Announces the Appointment of Suba Krishnan, M.D. as Senior Vice President of Clinical Development, Effective December 7, 2020	23/11/20	CI
Mereo Biopharma Group plc Appoints Heidi Petersen as Senior Vice President, Regulatory Affairs	20/10/20	CI
Mereo BioPharma Group plc Announces Changes to Board of Directors	28/09/20	CI
Mereo Biopharma Group plc Appoints Michael Wyzga as Interim Chief Financial Officer	03/08/20	CI
Mereo Biopharma Group plc Cease Michael Wyzga as Member of Audit and Risk Committee	03/08/20	CI
Richard Jones Announces Step Down from the Board of Mereo BioPharma Group plc	30/06/20	CI
Mereo BioPharma Group plc Appoints John Lewicki, as Chief Scientific Officer and Ann Kapoun as SVP of Translational Research and Development	30/06/20	CI
Mereo BioPharma Group plc Appoints Arun Mistry as Therapeutic Area Head, Setrusumab	17/09/19	CI
Mereo BioPharma Group plc Appoints Richard Francis as Head of Pharmaceutical Development, Effective August 1, 2019	16/07/19	CI
Mereo BioPharma Group plc Announces Board Appointments	23/04/19	CI
Mereo Biopharma Group plc Announces Board Changes	11/02/19	CI
Mereo BioPharma Group plc Announces Board Appointments	05/12/18	CI
Mereo BioPharma Group plc Appoints Wills Hughes-Wilson as Head of Patient Access and Commercial Planning	26/02/18	CI
Mereo Biopharma Group plc Appoints Richard CM Jones as Chief Financial Officer and Board of Director	07/11/16	CI
Richard Bungay to Leave Mereo BioPharma Group plc as Chief Financial Officer and Chief Operating Officer in April 2017	05/10/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer